CATO BIOVENTURES
Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization (CRO). For over 20 years, Cato BioVentures and Cato Research have partnered with entrepeneurs, academic institutions, and a broad base of biotech and pharmaceutical companies to advance a robust portfolio of sucessful product development programs. They focus on early to mid-stage investment opportunities in private companies and undervalued public companies. Through s... trategic CRO service agreements with Cato Research, They have invested their CRO Service Capitalรขยยข in innovative therapeutics, medical devices and stem cell technologies that improve Pharma's Research and Development productivity. If strategic outsourcing for development and regulatory support is a core component of a company's business plan, then their investment model can make a positive difference in the company's overall success.
CATO BIOVENTURES
Social Links:
Status:
Active
Contact:
919-361-2290
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Content Delivery Network IPv6 AJAX Libraries API PHP Cloudflare PHP 7
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2007-04-13 | PluroGen Therapeutics | Cato BioVentures investment in Seed Round - PluroGen Therapeutics | 1.7 M USD |
Newest Events participated
Participated in BIO-Europe 2017 | November 6โ8 in Berlin, Germany
on 2017-11-06 as exhibitor
More informations about "Cato BioVentures"
Michael Cato - Principal - Cato BioVentures - LinkedIn
Principal at Cato BioVentures · Mr. Cato has more than 20 yearsโ experience in management, including expertise in quality assurance and<br>research. ... Get in touch if you or your โฆSee details»
CATO SMS is Now Allucent
MAY 2, 2022 New Name and Branding Reflect Companyโs Mission to Help Bring Next-Generation Therapies to Light News Summary CARY, N.C., May 2, 2022 โ Global biopharmaceutical services leader, CATO SMS, today unveiled its new โฆSee details»
CATO Research Announces Merger With SMS โฆ
OCTOBER 28, 2019 Combination Broadens Companyโs Global Solutions Supporting Drug Development DURHAM, N.C. โ Cato Research, LLC (CATO) announced today that it has merged with Specialized Medical Services โฆSee details»
Cato BioVentures is based in San Diego, U.S.A. | Angels Partners
Cato BioVentures is the venture capital affiliate of Cato Research. The firm has partnered with entrepreneurs, academic institutions and a broad base of biotech and pharmaceutical โฆSee details»
Cato BioVentures - Investments, Portfolio & Company Exits
Apr 13, 2007 Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization (CRO).See details»
Cato BioVentures Investor Profile: Portfolio & Exits
Cato BioVentures's latest investment was on 16-Oct-2019 in Vaccicure, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure youโre getting the most โฆSee details»
Cato BioVentures, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cato BioVentures, Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
Cato BioVentures - Contacts, Employees, Board Members
Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization (CRO).See details»
Cato BioVentures - Company Profile and News - Bloomberg Markets
Cato BioVentures operates as a venture capital firm. The Company invests in life sciences, clinical development, regulatory affairs, and manufacturing sectors. Cato BioVentures serves โฆSee details»
ADial Pharmaceuticals Announces Strategic Partnership With
Nov 4, 2013 Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization (CRO). For 25 years, Cato BioVentures and โฆSee details»
Jenken Biosciences, Cato Research And Cato BioVentures Sign
Nov 20, 2006 RESEARCH TRIANGLE PARK, N.C., Nov. 20 /PRNewswire/ -- Jenken Biosciences, Inc., an emerging specialty pharmaceutical company, today announced that it โฆSee details»
Cato BioVentures - Tech Stack, Apps, Patents & Trademarks
Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization (CRO).See details»
Cato BioVentures Seeks Strategic Marketing Partner For FDA
Dec 8, 2005 DURHAM, N.C., Dec. 7 /PRNewswire/ -- Cato BioVentures, the venture capital affiliate of Cato Research Ltd., a leading contract research organization, announced today its โฆSee details»
Cordex Pharma Announces Strategic Master Services ... - Fierce โฆ
Feb 23, 2009 Cato BioVentures is the venture capital affiliate of Cato Research Ltd. For nearly 20 years, Cato BioVentures has assisted entrepreneurs and established management teams โฆSee details»
Cato Bioventures Inc - Company Profile and News
Cato Bioventures Inc. Cato Holding Company, doing business as Cato Research Ltd., operates as a holding company. The Company, through its subsidiaries, provides contract research and โฆSee details»
VistaGen Increases Its Drug Rescue Opportunities
Feb 9, 2012 Under the new agreement, when either Cato BioVentures or Cato Research first becomes aware of a new drug candidate meeting VistaGen's drug rescue selection criteria, it โฆSee details»
Cato BioVentures - Updates, News, Events, Signals & Triggers
Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization (CRO).See details»
Advanced Pain Remedies, a Subsidiary of Cato BioVentures, โฆ
Jan 10, 2011 /PRNewswire/ -- Advanced Pain Remedies (APR), a subsidiary of Cato BioVentures, announces that a three million dollar grant has been received, to advance its...See details»
Lynda Sutton - President @ Cancer Advances - Crunchbase
Lynda Sutton is the President of Cancer Advances and Cato Bioventures and was a Co-founder, President, and Chief Regulatory Officer at SMS-oncology. She attended Troy University. Jobs. โฆSee details»